Action on Hearing Loss Logo
    Total results:
      Total results:

      Charity welcomes CCGs decision to save hearing aid provision

      16 June 2017

      National charity, Action on Hearing Loss, has welcomed Milton Keynes CCG’s decision not to cut hearing aid provision following public consultation.

      Following an eight week consultation period which included engagement with the charity, patients, members of the public, providers and other stakeholders, the CCG Board decided not to cut hearing aids for people with mild hearing loss and limit provision for those with moderate hearing loss. It also decided continue providing two hearing aids rather than just one.

      The charity engaged directly with the CCG on its proposals and highlighted both the benefits of hearing aids and ways it can save money by improving how these services are commissioned.

      Dr. Roger Wicks, Director of Policy and Campaigns at Action on Hearing Loss, said: “We’re delighted that Milton Keynes CCG has decided not to move forward with its original proposals for hearing services. The Board has positively engaged and listened to both public opinion and the robust evidence of the clinical effectiveness of hearing aids.

      “Hearing aids are a lifeline to many, enabling people with hearing loss to remain in work and to maintain their social lives. While we know that health commissioners across the country are needing to make significant and urgent savings, we’re pleased to see Milton Keynes CCG welcoming alternative measures to cuts.”

      To find out more about Action on Hearing Loss, please visit:


      For media enquiries or comment

      Jess Reid, PR Officer, telephone: 0203 227 6065 or email, @hearinglossPR.

      Notes to Editors
      • Action on Hearing Loss (formerly RNID) is the national charity helping people confronting deafness, tinnitus and hearing loss to live the life they choose. Action on Hearing Loss enables them to take control of their lives and remove the barriers in their way, giving people support and care, developing technology and treatments, and campaigning for equality.